Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327922 · ClinicalTrials.gov registry record · NA
Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis
A NA study of Interrupted Subdermal Suture, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03327922: Completed NA study of Interrupted Subdermal Suture, sponsored by University of California, Davis.
NCT03327922 is a NA study of Interrupted Subdermal Suture that has completed, run by University of California, Davis. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03327922, a NA study of Interrupted Subdermal Suture, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated subdermal sutures or fewer, more widely spaced subdermal sutures. The investigator wishes to compare the effects of one versus two centimeter spacing between sutures.
Primary Outcome
The primary endpoint will be the score of two blinded reviewers using the patient observer scar assessment score (POSAS). The POSAS measures scar quality in all types of scars by evaluating visual (e.g. color), tactile (e.g. pliability) and sensory (e.g. itch) characteristics of the scar from the perspective of the observer and patients. Scores for each subscale range from 1 to 10, for a sum score range from 6 to 60. Low scores indicate better outcomes.
Conditions Studied
Interventions
- DEVICE Vicryl absorbable suture
Study Locations (1)
California
- University of California, Davis, Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2022-03-02 |
| Phase | NA |
What the finished NCT03327922 record still lists
NCT03327922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Interrupted Subdermal Suture appearing as the primary indexed condition, and to 1 intervention - of which Vicryl absorbable suture is the first listed.
NCT03327922 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03327922 about?
NCT03327922 is a clinical study titled "Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis". This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approxi...
What is the current status of trial NCT03327922?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-20. Estimated completion is 2022-03-02.
What conditions does trial NCT03327922 study?
This clinical trial studies the following conditions: Interrupted Subdermal Suture.
What interventions are being tested in trial NCT03327922?
The interventions under investigation include: Vicryl absorbable suture (DEVICE).
Who is sponsoring clinical trial NCT03327922?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03327922 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03327922's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI